Cargando…

3,5,3′-Triiodo-L-Thyronine- and 3,5-Diiodo-L-Thyronine- Affected Metabolic Pathways in Liver of LDL Receptor Deficient Mice

3,5,3′-triiodo-L-thyronine (T3) and 3,5-diiodo-L-thyronine (T2), when administered to a model of familial hypercholesterolemia, i.e., low density lipoprotein receptor (LDLr)-knockout (Ldlr(−/−)) mice fed with a Western type diet (WTD), dramatically reduce circulating total and very low-density lipop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moreno, Maria, Silvestri, Elena, Coppola, Maria, Goldberg, Ira J., Huang, Li-Shin, Salzano, Anna M., D'Angelo, Fulvio, Ehrenkranz, Joel R., Goglia, Fernando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112267/ https://www.ncbi.nlm.nih.gov/pubmed/27909409 http://dx.doi.org/10.3389/fphys.2016.00545

Ejemplares similares

Proteomic approaches for the study of tissue specific effects of 3,5,3′-triiodo-L-thyronine and 3,5-diiodo-L-thyronine in conditions of altered energy metabolism
por: Silvestri, Elena, et al.
Publicado: (2014)

Both 3,5-Diiodo-L-Thyronine and 3,5,3′-Triiodo-L-Thyronine Prevent Short-term Hepatic Lipid Accumulation via Distinct Mechanisms in Rats Being Fed a High-Fat Diet
por: Senese, Rosalba, et al.
Publicado: (2017)

Nonthyrotoxic Prevention of Diet-Induced Insulin Resistance by 3,5-Diiodo-L-Thyronine in Rats
por: de Lange, Pieter, et al.
Publicado: (2011)

Assay of Endogenous 3,5-diiodo-L-thyronine (3,5-T(2)) and 3,3′-diiodo-L-thyronine (3,3′-T(2)) in Human Serum: A Feasibility Study
por: Lorenzini, Leonardo, et al.
Publicado: (2019)

3,5-Diiodo-L-Thyronine Activates Brown Adipose Tissue Thermogenesis in Hypothyroid Rats
por: Lombardi, Assunta, et al.
Publicado: (2015)

Anti-Apoptotic Effects of 3,3’,5-Triiodo-L-Thyronine in the Liver of Brain-Dead Rats
por: Rebolledo, Rolando A., et al.
Publicado: (2015)

miR-22-3p is involved in gluconeogenic pathway modulated by 3,5-diiodo-L-thyronine (T2)
por: Senese, Rosalba, et al.
Publicado: (2019)

3,5-Diiodo-L-Thyronine Exerts Metabolically Favorable Effects on Visceral Adipose Tissue of Rats Receiving a High-Fat Diet
por: Silvestri, Elena, et al.
Publicado: (2019)

Evaluation of Cardioprotective Effect of 3,5,3′-Tri-iodo-L-thyronine in Isoproterenol-Induced Cardiotoxicity
por: Mishra, Vinay, et al.
Publicado: (2011)

3,5,3'-Triiodo-L-Thyronine Regulates Actin Cytoskeleton Dynamic in The Differentiated PC-12 Cells during Hypoxia through An αvβ3 Integrin
por: Barbakadze, Tamar, et al.
Publicado: (2023)

3,5-Diiodo-L-Thyronine Affects Structural and Metabolic Features of Skeletal Muscle Mitochondria in High-Fat-Diet Fed Rats Producing a Co-adaptation to the Glycolytic Fiber Phenotype
por: Silvestri, Elena, et al.
Publicado: (2018)

Genomic and Non-Genomic Mechanisms of Action of Thyroid Hormones and Their Catabolite 3,5-Diiodo-L-Thyronine in Mammals
por: Giammanco, Marco, et al.
Publicado: (2020)

3,5 Diiodo-l-Thyronine (T(2)) Promotes the Browning of White Adipose Tissue in High-Fat Diet-Induced Overweight Male Rats Housed at Thermoneutrality
por: Senese, Rosalba, et al.
Publicado: (2019)

3,5-Diiodo-L-Thyronine (T2) Administration Affects Visceral Adipose Tissue Inflammatory State in Rats Receiving Long-Lasting High-Fat Diet
por: Petito, Giuseppe, et al.
Publicado: (2021)

Hippocampal Gene Expression of Deiodinases 2 and 3 and Effects of 3,5-Diiodo-L-Thyronine T2 in Mouse Depression Paradigms
por: Markova, Natalyia, et al.
Publicado: (2013)

3,5-Diiodo-l-Thyronine Increases Glucose Consumption in Cardiomyoblasts Without Affecting the Contractile Performance in Rat Heart
por: Sacripanti, Ginevra, et al.
Publicado: (2018)

Both 3,3′,5-triiodothyronine and 3,5-diodo-L-thyronine Are Able to Repair Mitochondrial DNA Damage but by Different Mechanisms
por: Cioffi, Federica, et al.
Publicado: (2019)

3,5 Diiodo-L-Thyronine (T2) Does Not Prevent Hepatic Steatosis or Insulin Resistance in Fat-Fed Sprague Dawley Rats
por: Vatner, Daniel F., et al.
Publicado: (2015)

Plasma 3,3’,5-Triiodo-L-thyronine [T3] level mirrors changes in tumor markers in two cases of metastatic cancer of the breast and pancreas treated with exogenous L-T3
por: Rodríguez-Molinero, Alejandro, et al.
Publicado: (2018)

3,5-Diiodo-L-Thyronine Administration To Hypothyroid Rats Rapidly Enhances Fatty Acid Oxidation Rate and Bioenergetic Parameters in Liver Cells
por: Cavallo, Alessandro, et al.
Publicado: (2013)

Modified Low-Dose Triiodo-L-thyronine Therapy Safely Improves Function Following Myocardial Ischemia-Reperfusion Injury
por: Rajagopalan, Viswanathan, et al.
Publicado: (2017)

Monocrotophos Pesticide Decreases the Plasma Levels of Total 3,3′,5-Triiodo-l-Thyronine and Alters the Expression of Genes Associated with the Thyroidal Axis in Female Goldfish (Carassius auratus)
por: Zhang, Xiaona, et al.
Publicado: (2014)

Culture in Glucose-Depleted Medium Supplemented with Fatty Acid and 3,3′,5-Triiodo-l-Thyronine Facilitates Purification and Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes
por: Lin, Bin, et al.
Publicado: (2017)

3, 3′5 Triiodo L Thyronine Induces Apoptosis in Human Breast Cancer MCF-7cells, Repressing SMP30 Expression through Negative Thyroid Response Elements
por: Sar, Pranati, et al.
Publicado: (2011)

Correction: 3, 3′5 Triiodo L Thyronine Induces Apoptosis in Human Breast Cancer MCF-7cells, Repressing SMP30 Expression through Negative Thyroid Response Elements
por: Sar, Pranati, et al.
Publicado: (2013)

Safe Oral Triiodo-L-Thyronine Therapy Protects from Post-Infarct Cardiac Dysfunction and Arrhythmias without Cardiovascular Adverse Effects
por: Rajagopalan, Viswanathan, et al.
Publicado: (2016)

Comparison of Individual and Combined Effects of Four Endocrine Disruptors on Estrogen Receptor Beta Transcription in Cerebellar Cell Culture: The Modulatory Role of Estradiol and Triiodo-Thyronine
por: Jocsak, Gergely, et al.
Publicado: (2016)

2-Amino-4,6-dimethylpyrimidin-1-ium 2,3,5-triiodobenzoate 2,3,5-triiodobenzoic acid monosolvate
por: Malathy, Sevaiyan, et al.
Publicado: (2011)

Interactions of L-3,5,3'-Triiodothyronine, Allopregnanolone, and Ivermectin with the GABA(A) Receptor: Evidence for Overlapping Intersubunit Binding Modes
por: Westergard, Thomas, et al.
Publicado: (2015)

4-(4-Pyridyl)pyridinium 3-amino-5-carboxy-2,4,6-triiodobenzoate–5-amino-2,4,6-triiodoisophthalic acid (1/1)
por: Zhang, Kou-Lin, et al.
Publicado: (2010)

Correction: Interactions of L-3,5,3'-Triiodothyronine, Allopregnanolone, and Ivermectin with the GABA(A) Receptor: Evidence for Overlapping Intersubunit Binding Modes
por: Westergard, Thomas, et al.
Publicado: (2015)

Diethyl 5-amino-2,4,6-triiodoisophthalate
por: Wu, Jun, et al.
Publicado: (2009)

Dimethyl 5-amino-2,4,6-triiodoisophthalate
por: Zou, Pei, et al.
Publicado: (2010)

2-[(Z)-(3-{[(Z)-2-Hydroxy-3,5-diiodobenzylidene]amino}propylimino)methyl]-4,6-diiodophenol
por: Kargar, Hadi, et al.
Publicado: (2012)

3,5,3′,5′-Tetramethyl-4,4′-bi(1H-pyrazolyl) hemihydrate
por: Jin, Shouwen, et al.
Publicado: (2012)

3,5,3′-Triiodothyronine–Loaded Liposomes Inhibit Hepatocarcinogenesis Via Inflammation-Associated Macrophages
por: Sun, Gangqi, et al.
Publicado: (2022)

(E)-N′-(2-Hydroxy-3,5-diiodobenzylidene)-3-methylbenzohydrazide
por: Tang, Chun-Bao
Publicado: (2012)

N′-[(E)-2-Hydroxy-3,5-diiodobenzylidene]pyridine-3-carbohydrazide
por: Thirugnanasundar, A., et al.
Publicado: (2011)

3-Bromo-N′-(2-hydroxy-3,5-diiodobenzylidene)benzohydrazide monohydrate
por: Ning, Jing-Heng, et al.
Publicado: (2009)

Effects of Different Amounts of Supplemental Selenium and Vitamin E on the Incidence of Retained Placenta, Selenium, Malondialdehyde, and Thyronines Status in Cows Treated with Prostaglandin F(2α) for the Induction of Parturition
por: Jovanović, Ivan B., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hgcb130uqgbkr1vda81s8gea9j